pDEST53-LRRK2-G2019S Citations (4)

Originally described in: Kinase activity is required for the toxic effects of mutant LRRK2/dardarin.
Greggio E, Jain S, Kingsbury A, Bandopadhyay R, Lewis P, Kaganovich A, van der Brug MP, Beilina A, Blackinton J, Thomas KJ, Ahmad R, Miller DW, Kesavapany S, Singleton A, Lees A, Harvey RJ, Harvey K, Cookson MR Neurobiol Dis. 2006 Aug . 23(2):329-41. PubMed Journal

---

Articles Citing pDEST53-LRRK2-G2019S

Articles
Threonine 56 phosphorylation of Bcl-2 is required for LRRK2 G2019S-induced mitochondrial depolarization and autophagy. Su YC, Guo X, Qi X. Biochim Biophys Acta. 2015 Jan;1852(1):12-21. doi: 10.1016/j.bbadis.2014.11.009. Epub 2014 Nov 15. PubMed
Wild-type and mutant (G2019S) leucine-rich repeat kinase 2 (LRRK2) associate with subunits of the translocase of outer mitochondrial membrane (TOM) complex. Neethling A, Engelbrecht L, Loos B, Kinnear C, Theart R, Abrahams S, Niesler T, Mellick GD, Williams M, Bardien S. Exp Cell Res. 2019 Feb 15;375(2):72-79. doi: 10.1016/j.yexcr.2018.12.022. Epub 2018 Dec 28. PubMed
Glial Nrf2 signaling mediates the neuroprotection exerted by Gastrodia elata Blume in Lrrk2-G2019S Parkinson's disease. Lin YE, Lin CH, Ho EP, Ke YC, Petridi S, Elliott CJ, Sheen LY, Chien CT. Elife. 2021 Nov 15;10. pii: 73753. doi: 10.7554/eLife.73753. PubMed
Pathogenic LRRK2 regulates centrosome cohesion via Rab10/RILPL1-mediated CDK5RAP2 displacement. Fdez E, Madero-Perez J, Lara Ordonez AJ, Naaldijk Y, Fasiczka R, Aiastui A, Ruiz-Martinez J, Lopez de Munain A, Cowley SA, Wade-Martins R, Hilfiker S. iScience. 2022 May 30;25(6):104476. doi: 10.1016/j.isci.2022.104476. eCollection 2022 Jun 17. PubMed

If you have published an article using this material, please email us at to have your article added to this page.